(Q73432094)

English

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?

scientific article published on 01 June 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764397%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT? (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764397%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Beevers DG

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764397%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Lee KW

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764397%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Lip GY

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764397%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764397%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Journal of Human Hypertension

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764397%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764397%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764397%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

367-372

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12764397%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1001556

0 references

Why are thiazide diuretics declining in popularity?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001556

7 January 2021

based on heuristic

inferred from DOI database lookup

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001556

7 January 2021

based on heuristic

inferred from DOI database lookup

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001556

7 January 2021

based on heuristic

inferred from DOI database lookup

Antihypertensive drug therapies and the risk of ischemic stroke

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001556

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001556

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001556

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001556

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001556

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001556

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001556

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001556

7 January 2021

based on heuristic

inferred from DOI database lookup

Contemporary treatment of heart failure: is there adequate evidence to support a unique strategy for African-Americans? Pro position

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001556

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001556

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001556

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001556

7 January 2021

based on heuristic

inferred from DOI database lookup

Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001556

7 January 2021

based on heuristic

inferred from DOI database lookup

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001556

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73432094&oldid=1723285127"